Literature DB >> 24206937

Neuropathogenesis of delirium: review of current etiologic theories and common pathways.

José R Maldonado1.   

Abstract

Delirium is a neurobehavioral syndrome caused by dysregulation of neuronal activity secondary to systemic disturbances. Over time, a number of theories have been proposed in an attempt to explain the processes leading to the development of delirium. Each proposed theory has focused on a specific mechanism or pathologic process (e.g., dopamine excess or acetylcholine deficiency theories), observational and experiential evidence (e.g., sleep deprivation, aging), or empirical data (e.g., specific pharmacologic agents' association with postoperative delirium, intraoperative hypoxia). This article represents a review of published literature and summarizes the top seven proposed theories and their interrelation. This review includes the "neuroinflammatory," "neuronal aging," "oxidative stress," "neurotransmitter deficiency," "neuroendocrine," "diurnal dysregulation," and "network disconnectivity" hypotheses. Most of these theories are complementary, rather than competing, with many areas of intersection and reciprocal influence. The literature suggests that many factors or mechanisms included in these theories lead to a final common outcome associated with an alteration in neurotransmitter synthesis, function, and/or availability that mediates the complex behavioral and cognitive changes observed in delirium. In general, the most commonly described neurotransmitter changes associated with delirium include deficiencies in acetylcholine and/or melatonin availability; excess in dopamine, norepinephrine, and/or glutamate release; and variable alterations (e.g., either a decreased or increased activity, depending on delirium presentation and cause) in serotonin, histamine, and/or γ-aminobutyric acid. In the end, it is unlikely that any one of these theories is fully capable of explaining the etiology or phenomenologic manifestations of delirium but rather that two or more of these, if not all, act together to lead to the biochemical derangement and, ultimately, to the complex cognitive and behavioral changes characteristic of delirium.
Copyright © 2013 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; delirium; encephalopathy; large neutral amino acids; neuroendocrine; neuroinflammation; oxidative stress; physiologic stress

Mesh:

Substances:

Year:  2013        PMID: 24206937     DOI: 10.1016/j.jagp.2013.09.005

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  164 in total

1.  Epigenetics of neuroinflammation: Immune response, inflammatory response and cholinergic synaptic involvement evidenced by genome-wide DNA methylation analysis of delirious inpatients.

Authors:  Taku Saito; Hiroyuki Toda; Gabrielle N Duncan; Sydney S Jellison; Tong Yu; Mason J Klisares; Sophia Daniel; Allison J Andreasen; Lydia R Leyden; Mandy M Hellman; Eri Shinozaki; Sangil Lee; Aihide Yoshino; Hyunkeun R Cho; Gen Shinozaki
Journal:  J Psychiatr Res       Date:  2020-06-06       Impact factor: 4.791

Review 2.  Statins and delirium: is there a role?

Authors:  Margarita Taburyanskaya; Tanna Hassig
Journal:  Curr Atheroscler Rep       Date:  2015-01       Impact factor: 5.113

Review 3.  Postoperative Delirium in the Geriatric Patient.

Authors:  Katie J Schenning; Stacie G Deiner
Journal:  Anesthesiol Clin       Date:  2015-07-07

Review 4.  Management of delirium in palliative care: a review.

Authors:  Luigi Grassi; Augusto Caraceni; Alex J Mitchell; Maria Giulia Nanni; Maria Alejandra Berardi; Rosangela Caruso; Michelle Riba
Journal:  Curr Psychiatry Rep       Date:  2015-03       Impact factor: 5.285

Review 5.  Gender differences in factors associated with delirium severity in older adults with dementia.

Authors:  Ann M Kolanowski; Nikki L Hill; Esra Kurum; Donna M Fick; Andrea M Yevchak; Paula Mulhall; Linda Clare; Michael Valenzuela
Journal:  Arch Psychiatr Nurs       Date:  2014-02-05       Impact factor: 2.218

6.  Increased Symptom Expression among Patients with Delirium Admitted to an Acute Palliative Care Unit.

Authors:  Maxine de la Cruz; Sriram Yennu; Diane Liu; Jimin Wu; Akhila Reddy; Eduardo Bruera
Journal:  J Palliat Med       Date:  2017-02-03       Impact factor: 2.947

Review 7.  Prevention of post-operative delirium in older patients with cancer undergoing surgery.

Authors:  Beatriz Korc-Grodzicki; James C Root; Yesne Alici
Journal:  J Geriatr Oncol       Date:  2014-10-23       Impact factor: 3.599

8.  Agitation, Delirium, and Cognitive Outcomes in Intracerebral Hemorrhage.

Authors:  Lisa J Rosenthal; Brandon A Francis; Jennifer L Beaumont; David Cella; Michael D Berman; Matthew B Maas; Eric M Liotta; Robert Askew; Andrew M Naidech
Journal:  Psychosomatics       Date:  2016-08-05       Impact factor: 2.386

9.  Benzodiazepines and Development of Delirium in Critically Ill Children: Estimating the Causal Effect.

Authors:  Kalgi Mody; Savneet Kaur; Elizabeth A Mauer; Linda M Gerber; Bruce M Greenwald; Gabrielle Silver; Chani Traube
Journal:  Crit Care Med       Date:  2018-09       Impact factor: 7.598

10.  Symptom Expression in Patients with Advanced Cancer Admitted to an Acute Supportive/Palliative Care Unit With and Without Delirium.

Authors:  Sebastiano Mercadante; Claudio Adile; Patrizia Ferrera; Andrea Cortegiani; Alessandra Casuccio
Journal:  Oncologist       Date:  2018-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.